December 2020 : Cardiac dysfunction in a patient treated with cabozantinib.
What do we know about cardiotoxicity of VEGF-inhibitors?
Presenters: Sebastian Szmit, MD, PhD (cardio-oncologist) & Michał Wilk, MD
Department of Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland
